Novo Holdings A/S - 07 Feb 2025 SCHEDULE 13G Report for ArriVent BioPharma, Inc. Common Stock, par value $0.0001 per share

Filing Manager: Novo Holdings A/S
Reporting Manager: Novo Holdings A/S
Security: ArriVent BioPharma, Inc. Common Stock, par value $0.0001 per share
Shares outstanding: 33.7M shares
Disclosed Ownership: 1.75M shares
Ownership: 5.2%
Form type: SCHEDULE 13G
Filing time: 14 Feb 2025, 21:00:03 UTC
Date of event: 07 Feb 2025
Next filing: 14 Aug 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Novo Holdings A/S	5.2%	1.75M	1.75M	0	Barbara Fiorini	Barbara Fiorini, General Counsel, Finance & Operations